Neuren Pharmaceuticals LimitedASX: NEU

FDA approval for Pitt Hopkins syndrome IND and Phase 2 trial

Mar 25, 2022 at 3:14 AM UTC · Issued by Neuren Pharmaceuticals Limited

Neuren Pharmaceuticals Ltd has released a press release.

View Attachment